Skip to main content

Table 5 Correlation between underlying disease and drugs with outcomes

From: COVID-19 in renal transplant recipients and general population: a comparative study of clinical, laboratory, and radiological features, severity, and outcome

 

Non-transplanted

EXPIRED

P

ICU admission

P

MV

P

Total adverse outcomes

P

PMH.HTN

No

0 (0.0)

0.022

6 (26.1)

0.580

0 (0.0)

0.015

6 (26.1)

0.340

Yes

4 (25.0)

 

4 (28.6)

 

4 (28.6)

 

6 (37.5)

 

PMH. diabetes

No

1 (3.7)

0.078

9 (33.3)

0.159

2 (7.7)

0.341

9 (33.3)

0.450

Yes

3 (25.0)

 

1 (10.0)

 

2 (18.)

 

3 (25.0)

 

PMH.CVA

No

4 (10.5)

0.897

10 (27.8)

0.730

4 (11.1)

0.892

12 (31.6)

0.692

Yes

0 (0.0)

 

0 (0.0)

 

0 (0.0)

 

0 (0.0)

 

Corticosteroid

No

5 (13.9)

0.573

8 (24.2)

0.291

3 (8.8)

0.372

11 (30.6)

0.392

Yes

0

 

2 (50.0)

 

1 (25.0)

 

2 (50.0)

 
  

(0.0)

       

ARB or ACEi

No

0 (0.0)

0.034

7 (28.0)

0.429

1 (4.2)

0.253

7 (28.0)

0.571

Yes

3 (23.1)

 

2 (18.2)

 

2 (16.7)

 

4 (30.8)

 

Atorvastatin

No

3 (12.0)

0.273

8 (34.8)

0.095

2 (8.7)

0.402

10 (40.0)

0.039

Yes

0 (0.0)

 

1 (8.3)

 

0 (0.0)

 

1 (7.7)

 

Warfarin

No

2 (5.6)

0.154

7 (21.2)

0.061

1 (2.9)

0.110

9 (25.0)

0.078

Yes

1 (50.0)

 

2 (100.0)

 

1 (50.0)

 

2 (100.0)

 
 

t-Transplanted

Expired (%)

P

ICU admission (%)

P

MV (%)

P

Bad outcome (%)

Total (%)

P

Donor

Live

3

0.701

3

0.670

3

0.635

4

13

0.5677

 

23.1

 

25.0

 

27.3

 

30.8

100.0

 

Deceased

1

 

1

 

1

 

1

5

 
 

20.0

 

20.0

 

20.0

 

20.0

100.0

 

Duration of transplantation

Mean

11.17

0.210

10.00

0.373

11.17

0.165

10.33

8.96

0.294

SD

7.25

 

6.46

 

7.25

 

6.12

4.94

 

Median

11.50

 

9.50

 

11.50

 

10.00

9.00

 

Percentile 25

3.00

 

4.00

 

3.00

 

5.00

5.00

 

Percentile 75

18.00

 

15.00

 

18.00

 

13.00

12.00

 

PMH.HTN

No

0

0.384

1

0.709

0

0.342

1

3

0.668

 

0.0

 

33.3

 

0.0

 

33.3

100.0

 

Yes

6

 

7

 

6

 

8

20

 
 

30.0

 

36.8

 

33.3

 

40.0

100.0

 

PMH. diabetes

No

3

0.639

4

0.670

3

0.633

5

12

0.567

 

25.0

 

36.4

 

27.3

 

41.7

100.0

 

YES

3

 

4

 

3

 

4

11

 
 

27.3

 

36.4

 

30.0

 

36.4

100.0

 

PMH.CVA

NO

6

0.739

8

0.636

6

0.714

9

22

0.609

 

27.3

 

38.1

 

30.0

 

40.9

100.0

 

Yes

0

 

0

 

0

 

0

1

 
 

0.0

 

0.0

 

0.0

 

0.0

100.0

 

Cyclosporine

No

2

0.463

3

0.454

2

0.477

3

10

0.363

 

20.0

 

30.0

 

22.2

 

30.0

100.0

 

Yes

4

 

5

 

4

 

6

13

 
 

30.8

 

41.7

 

33.3

 

46.2

100.0

 

Tacrolimus

No

3

0.683

4

0.681

3

0.704

5

13

0.584

 

23.1

 

33.3

 

25.0

 

38.5

100.0

 

Yes

2

 

3

 

2

 

3

9

 
 

22.2

 

33.3

 

25.0

 

33.3

100.0

 

Sirolimus

No

6

0.739

8

0.636

6

0.714

9

22

0.609

 

27.3

 

38.1

 

30.0

 

40.9

100.0

 

Yes

0

 

0

 

0

 

0

1

 
 

0.0

 

0.0

 

0.0

 

0.0

100.0

 

Corticosteroid

No

0

0.750

0

_

0

_

0

1

0.625

 

0.0

 

0.0

 

0.0

 

0.0

100.0

 

Yes

6

 

8

 

6

 

9

23

 
 

26.1

 

34.8

 

27.3

 

39.1

100.0

 

ARB or ACEi

No

4

0.480

5

0.165

4

0.480

6

18

0.397

 

22.2

 

27.8

 

22.2

 

33.3

100.0

 

Yes

2

 

3

 

2

 

3

6

 
 

33.3

 

50.0

 

33.3

 

50.0

100.0

 

Atorvastatin

No

0

0.228

1

0.593

0

0.288

1

4

0.514

 

0.0

 

25.0

 

0.0

 

25.0

100.0

 

Yes

6

 

7

 

6

 

8

20

 
 

30.0

 

35.0

 

30.0

 

40.0

100.0

 

Warfarin

No

6

0.739

8

0.636

6

0.714

9

22

0.609

 

27.3

 

38.1

 

30.0

 

40.9

100.0

 

Yes

0

 

0

 

0

 

0

1

 
 

0.0

 

0.0

 

0.0

 

0.0

100.0

Â